Position in QGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,850,250
+$1,524,534 QoQ
Shares Held
277,500
+19.1% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#71
of 332 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Derivatives in QGEN
reported options exposure · as of Mar 31, 2026CallValue
$4,004,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $42,778,768 across 6 Diagnostics & Research names. QGEN ranks #2 (25.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MTD |
Mettler Toledo International Inc/
|
22,000 | $28,105,220 | |
| 2 | QGEN |
Qiagen N.V.
This page
|
277,500 | $10,850,250 | |
| 3 | GH |
Guardant Health, Inc.
|
19,360 | $2,904,580 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
680 | $357,979 | |
| 5 | WAT |
Waters Corp /De/
|
800 | $300,032 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
520 | $260,707 |
All Filings in QGEN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,850,250 | 277,500 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,004,000 | 100,000 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $9,325,716 | 232,910 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||